BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Job Trends

  6 Companies Hiring in Texas

  Looking for a biopharma job in Texas? Check out the BioSpace list of six companies hiring life sciences professionals like you.

  August 14, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  PODCAST

  The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know

  In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy changes with Aaron Cummings and Anne Li of Brownstein Hyatt Farber Schreck.

  August 14, 2025

   · 

  1 min read

   · 

  Lori Ellis
• 

  Layoffs

  Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis

  Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy VE202 failed to demonstrate significant response rates in patients with ulcerative colitis.

  August 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Tariffs

  Trump Tarries on Tariffs Again, Delays Plans by Weeks: Report

  Citing other priorities—such as the upcoming U.S.-Russia summit—four anonymous sources claim that pharma tariffs could still be weeks away, according to Reuters.

  August 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Inflammatory bowel disease

  CytomX Reports Treatment-Related Patient Death in Phase I Colorectal Cancer Study

  The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” according to CytomX.

  August 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pipeline

  Schrödinger Cans Early-Stage Blood Cancer Drug After Two Patient Deaths

  After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be “difficult,” according to Schrödinger, whose stock dropped 17.5% before the opening bell on Thursday.

  August 14, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  WARN Act 101: How It Actually Works

  WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An attorney explains how the law works, common misconceptions about it and how it helps those about to lose their jobs.

  August 14, 2025

   · 

  5 min read

   · 

  Angela Gabriel
• 

  Obesity

  Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership

  The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for Lilly.

  August 14, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• 

  Drug pricing

  Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy

  As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.

  August 14, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Editorial

  RFK Jr. Creates More Vaccine Misinformation With mRNA Cancellations

  The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S. government has already spent billions on this work, which has saved millions of lives.

  August 14, 2025

   · 

  4 min read

   · 

  Dan Samorodnitsky